Media Advisory

From Startup Medaware

Link to Full Article:

MedAware CEO to Present How Machine Learning Can Eradicate Catastrophic Medication Errors at Allscripts Client Experience
WHO: Gidi Stein, MD PhD, co-founder and CEO of MedAware, a provider of algorithm-rich solutions for the detection and elimination of significant medication errors. MedAware’s patent-pending technology uses big data analytics and machine-learning algorithms to analyze Electronic Medical Records (EMR) and provide more effective alerts to physicians to identify and eradicate prescription mistakes. MedAware’s decision support and risk management tools improve patient safety measures while also reducing risk and providing great economic benefit to healthcare providers.
WHAT: With a focus on precision medicine, the value of analytics to improve population health, and interoperability and connectivity to the growing healthcare community, Allscripts Client Experience (ACE) 2017 will bring together world-class thought leaders and Allscripts’ clients. Guests will network and educate with fellow Allscripts user to discuss the future of the healthcare industry with an emphasis on smarter care.
To qualify the value of medication surveillance technology, Dr. Stein will present, “Leveraging Advanced Machine Learning to Eradicate Catastrophic Medication Errors.” In this session, attendees will receive an overview of how current rule-based systems fail to fully protect patients and providers from medication errors. The presentation will then demonstrate why a technology that leverages machine learning algorithms and outlier detection mechanisms, when paired with a rule-based system, saves lives, enhances patient safety and ultimately outcomes, and significantly reduces avoidable risks and costs.
Dr. Stein will also detail how MedAware’s medication surveillance solutions flag Rx outliers as potential errors and provides ongoing and active monitoring to identify Adverse Drug Events (ADE) and eradicate catastrophic prescription errors. Finally, he will highlight the economic benefits related to this new approach of protecting patients and physicians.
WHERE: McCormick Place Chicago, West Building2301 S. Prairie Ave, Chicago, IL 60616
WHEN: Tuesday, August 8, 4:00 PM – 5:00 PM CST and Wednesday, August 9, 3:30 PM – 4:30 PM CST
About MedAwareEach year, hundreds of thousands of Americans are injured or fatally harmed by adverse drug events (ADE) and erroneous prescriptions. MedAware’s medication surveillance technology identifies ADEs and eradicates catastrophic medication errors by applying advanced machine-learning algorithms, and outlier detection mechanisms similar to fraud detection solutions in use by financial institutions worldwide. By continuously mining data gathered via millions of electronic health records, the software is able to accurately flag potentially life-threatening prescriptions that are in conflict with the profile of the patient, physician, or institution.  In addition, MedAware actively monitors each patient to identify and warn of situations in which changes in a patient’s diagnostic results renders one of his/her active medications a dangerous outlier. These difficult or nearly impossible to anticipate errors would otherwise go undetected by current rule-based solutions.  The company’s unique, real-time approach to identifying ADEs and preventing medication errors saves lives, improves patient safety and outcomes, and significantly reduces avoidable risks and costs. For more information, please visit

Please visit their site for more information:

All,Analytics,Digital,Healthcare News,Startup News
2018-07-28 20:12:24